Peer-influenced content. Sources you trust. No registration required. This is HCN.

JAMA NetworkNew Test to Help Diagnose Alzheimer Disease

The Lumipulse G β-Amyloid Ratio (1-42/1-40) test could potentially eliminate the need for positron emission tomography (PET) scans to assess amyloid plaques in patients’ brains, Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, said in a statement.